CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Reitan Colleen F Director | Grant or award | +59,701 | 152,030 | ||
| 2025-06-05 | Reitan Colleen F Director | Grant or award | +49,796 | 92,329 | ||
| 2024-09-03 | Reitan Colleen F Director | Sale 10b5-1 | −46,012 | $27.95 | $1.3M | 42,533 |
| 2024-06-06 | Reitan Colleen F Director | Grant or award | +15,695 | 88,545 | ||
| 2023-06-01 | Reitan Colleen F Director | Grant or award | +15,151 | 72,850 | ||
| 2022-06-02 | Reitan Colleen F Director | Grant or award | +17,275 | 57,699 | ||
| 2021-06-03 | Reitan Colleen F Director | Grant or award | +12,848 | 40,424 | ||
| 2020-12-04 | Reitan Colleen F Director | Grant or award | +15,889 | 27,576 |
Page 1 of 1 · 8 trades